Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma
Clinical trial NCT05342792 · RECRUITING
Trial details
- NCT number
- NCT05342792
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-17
- Primary completion
- 2027-06-01
- Enrollment
- 556
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.